Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
cancer
100%
patients
74%
radiotherapy
67%
risks
49%
brachytherapy
38%
carcinomas
30%
women
19%
prostate
18%
tumors
18%
doses
18%
diseases
17%
toxicity
15%
comparative evaluations
15%
rectum
14%
images
14%
radiations
13%
control
12%
quality of life
12%
therapy
12%
beams
11%
symptoms
11%
prediction
11%
data
11%
hyperthermia
10%
volume
9%
classification
9%
nmr imaging
9%
combined therapy
8%
learning
8%
implants
8%
Keyphrases
Endometrial Cancer
46%
PORTEC
38%
Radiotherapy
29%
External Beam Radiotherapy
17%
Endometrial Carcinoma
16%
Brachytherapy
15%
Adjuvant Therapy
15%
Locally Advanced Cervical Cancer
15%
Radiation Therapy
15%
Vaginal Brachytherapy
14%
High-risk Endometrial Cancer
13%
Randomized Trial
12%
Intraoperative Radiation Therapy
12%
Intermediate Risk
10%
Prostate
10%
Hyperthermia
10%
Recurrence Risk
10%
Image-guided Brachytherapy
8%
Overall Survival
8%
Clinical Outcomes
8%
Molecular Classification
8%
Radiotherapy Alone
8%
Rectum
8%
Cervical Cancer
8%
Chemoradiotherapy
7%
Pelvic Radiotherapy
7%
Lymphovascular Invasion
7%
Cervical Carcinoma
7%
Health-related Quality of Life
7%
Prostate Radiotherapy
7%
Medicine and Dentistry
Uterine Cancer
56%
Radiation Therapy
46%
Brachytherapy
35%
Endometrium Carcinoma
20%
External Beam Radiotherapy
17%
Cervical Cancer
16%
Adjuvant Therapy
16%
Neoplasm
15%
Recurrent Disease
12%
Chemoradiotherapy
12%
Pelvis
11%
Quality of Life
11%
Protein P53
8%
Uterine Cervix Carcinoma
8%
Implant
7%
Recurrence Risk
7%
Magnetic Resonance Imaging
7%
Diseases
6%
Pelvic Radiotherapy
6%
Prostate Cancer
6%
DNA Mismatch Repair
5%
Malignant Neoplasm
5%
Adverse Event
5%
Overall Survival
5%
Cancer Therapy
5%
Citrulline
5%
High-Dose-Rate Brachytherapy
5%